BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
38.31
-0.05 (-0.13%)
At close: May 01, 2025, 3:21 PM
BridgeBio Pharma Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
50
Upside
30.51
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Scotiabank | Buy | Maintains | 52 55 | 43.57% | Apr 30, 2025 | |
| Piper Sandler | Buy | Maintains | 46 63 | 64.45% | Apr 30, 2025 | |
| UBS | Strong Buy | Maintains | 65 72 | 87.94% | Apr 30, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.